Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Simona Di Giambenedetto; C Pinnetti; F Maggiolo; P Lorenzini; M Fabbiani; C Tommasi; A Latini; A Ammassari; L Loiacono; G Sterrantino; R Bellagamba; E Boumis; A Antinori; M. Zaccarelli

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Simona Di Giambenedetto, C Pinnetti, F Maggiolo, P Lorenzini, M Fabbiani, C Tommasi, A Latini, A Ammassari, L Loiacono, G Sterrantino, R Bellagamba, E Boumis, A Antinori, M. Zaccarelli

Risultato della ricerca: Contributo in rivista › Contributo a convegno › peer review

Abstract

To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

Lingua originale	English
pagine (da-a)	19812-19812
Numero di pagine	1
Rivista	Journal of the International AIDS Society
Volume	17
Stato di pubblicazione	Pubblicato - 2014
Evento	HIV Drug Therapy Glasgow Congress 2014 - Glasgow Durata: 2 nov 2014 → 6 nov 2014

Keywords

HIV
simplification
therapy

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Di Giambenedetto, S., Pinnetti, C., Maggiolo, F., Lorenzini, P., Fabbiani, M., Tommasi, C., Latini, A., Ammassari, A., Loiacono, L., Sterrantino, G., Bellagamba, R., Boumis, E., Antinori, A., & Zaccarelli, M. (2014). Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort. Journal of the International AIDS Society, 17, 19812-19812.

@article{f65c8b1468454ab892fe0e02f7e4d07b,

title = "Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort",

abstract = "To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.",

keywords = "HIV, simplification, therapy, HIV, simplification, therapy",

author = "{Di Giambenedetto}, Simona and C Pinnetti and F Maggiolo and P Lorenzini and M Fabbiani and C Tommasi and A Latini and A Ammassari and L Loiacono and G Sterrantino and R Bellagamba and E Boumis and A Antinori and M. Zaccarelli",

year = "2014",

language = "English",

volume = "17",

pages = "19812--19812",

journal = "Journal of the International AIDS Society",

issn = "1758-2652",

publisher = "London: BioMed Central",

note = "HIV Drug Therapy Glasgow Congress 2014 ; Conference date: 02-11-2014 Through 06-11-2014",

}

Di Giambenedetto, S, Pinnetti, C, Maggiolo, F, Lorenzini, P, Fabbiani, M, Tommasi, C, Latini, A, Ammassari, A, Loiacono, L, Sterrantino, G, Bellagamba, R, Boumis, E, Antinori, A & Zaccarelli, M 2014, 'Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort', Journal of the International AIDS Society, vol. 17, pagg. 19812-19812.

TY - JOUR

T1 - Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

AU - Di Giambenedetto, Simona

AU - Pinnetti, C

AU - Maggiolo, F

AU - Lorenzini, P

AU - Fabbiani, M

AU - Tommasi, C

AU - Latini, A

AU - Ammassari, A

AU - Loiacono, L

AU - Sterrantino, G

AU - Bellagamba, R

AU - Boumis, E

AU - Antinori, A

AU - Zaccarelli, M.

PY - 2014

Y1 - 2014

N2 - To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

AB - To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

KW - HIV

KW - simplification

KW - therapy

KW - HIV

KW - simplification

KW - therapy

UR - http://hdl.handle.net/10807/61293

M3 - Conference article

VL - 17

SP - 19812

EP - 19812

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

SN - 1758-2652

T2 - HIV Drug Therapy Glasgow Congress 2014

Y2 - 2 November 2014 through 6 November 2014

ER -

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo